0001114220-18-000076.txt : 20180712
0001114220-18-000076.hdr.sgml : 20180712
20180712180013
ACCESSION NUMBER: 0001114220-18-000076
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20180630
FILED AS OF DATE: 20180712
DATE AS OF CHANGE: 20180712
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Morrison Jodie Pope
CENTRAL INDEX KEY: 0001618247
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-30929
FILM NUMBER: 18951305
MAIL ADDRESS:
STREET 1: C/O TOKAI PHARMACEUTICALS, INC.
STREET 2: ONE BROADWAY, 14TH FLOOR
CITY: CAMBRIDGE
STATE: MA
ZIP: 02142
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: KERYX BIOPHARMACEUTICALS INC
CENTRAL INDEX KEY: 0001114220
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 134087132
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: ONE MARINA PARK DR.
CITY: BOSTON
STATE: MA
ZIP: 02210
BUSINESS PHONE: 617-466-3500
MAIL ADDRESS:
STREET 1: ONE MARINA PARK DR.
CITY: BOSTON
STATE: MA
ZIP: 02210
4
1
wf-form4_153143279791914.xml
FORM 4
X0306
4
2018-06-30
0
0001114220
KERYX BIOPHARMACEUTICALS INC
KERX
0001618247
Morrison Jodie Pope
C/O KERYX BIOPHARMACEUTICALS, INC.
ONE MARINA PARK DRIVE, 12TH FLOOR
BOSTON
MA
02210
1
1
0
0
Interim CEO
Common Stock
2018-06-30
4
A
0
10000
0
A
120000
D
Stock Options (right to buy)
3.76
2018-06-30
4
A
0
30000
0
A
2019-06-30
2028-06-30
Common Stock
30000.0
30000
D
The 10,000 shares are restricted common stock, with one-third of the 10,000 shares vesting on each of June 30, 2019, June 30, 2020 and June 30, 2021.
Includes 116,666 shares of restricted stock.
The 30,000 stock options vest as to one-third on each of June 30, 2019, June 30, 2020 and June 30, 2021.
/s/ Scott A. Holmes, Attorney-in-Fact
2018-07-12